113 related articles for article (PubMed ID: 7547091)
1. The effects of age and gender on the pharmacokinetics of tenidap sodium in patients with rheumatoid arthritis and osteoarthritis.
Caldwell JR; Kirby DS; Gardner MJ; Hansen RA
Br J Clin Pharmacol; 1995; 39 Suppl 1(Suppl 1):3S-9S. PubMed ID: 7547091
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of tenidap sodium administered with food or antacid in healthy volunteers.
Coates PE; Mesure R
Br J Clin Pharmacol; 1995; 39 Suppl 1(Suppl 1):17S-19S. PubMed ID: 7547087
[TBL] [Abstract][Full Text] [Related]
3. Tenidap reduces the level of interleukin 1 receptors and collagenase expression in human arthritic synovial fibroblasts.
Martel-Pelletier J; Mineau F; Tardif G; Fernandes JC; Ranger P; Loose L; Pelletier JP
J Rheumatol; 1996 Jan; 23(1):24-31. PubMed ID: 8838504
[TBL] [Abstract][Full Text] [Related]
4. An investigation into the effect of tenidap sodium on the pharmacokinetics of a combined oral contraceptive.
Coates PE; Mesure R
Br J Clin Pharmacol; 1995; 39 Suppl 1(Suppl 1):47S-50S. PubMed ID: 7547095
[TBL] [Abstract][Full Text] [Related]
5. Cimetidine does not alter the clearance or plasma binding of tenidap in healthy male volunteers.
Wilner KD; Gardner MJ
Br J Clin Pharmacol; 1995; 39 Suppl 1(Suppl 1):21S-24S. PubMed ID: 7547088
[TBL] [Abstract][Full Text] [Related]
6. A pharmacokinetic model for tenidap in normal volunteers and rheumatoid arthritis patients.
Evans L; Aarons L; Coates P
Pharm Res; 1999 Oct; 16(10):1608-15. PubMed ID: 10554105
[TBL] [Abstract][Full Text] [Related]
7. The effect of tenidap sodium on the disposition and plasma protein binding of phenytoin in healthy male volunteers.
Blum RA; Schentag JJ; Gardner MJ; Wilner KD
Br J Clin Pharmacol; 1995; 39 Suppl 1(Suppl 1):35S-38S. PubMed ID: 7547092
[TBL] [Abstract][Full Text] [Related]
8. Single and multiple dose pharmacokinetics of tenidap sodium in healthy subjects.
Gardner MJ; Wilner KD; Hansen RA; Fouda HG; McMahon GF
Br J Clin Pharmacol; 1995; 39 Suppl 1(Suppl 1):11S-15S. PubMed ID: 7547086
[TBL] [Abstract][Full Text] [Related]
9. The effects of tenidap on canine experimental osteoarthritis: II. Study of the expression of collagenase-1 and interleukin 1beta by in situ hybridization.
Fernandes JC; Martel-Pelletier J; Jovanovic D; Tardif G; DiBattista JA; Lascau-Coman V; Otterness IG; Pelletier JP
J Rheumatol; 1998 May; 25(5):951-8. PubMed ID: 9598897
[TBL] [Abstract][Full Text] [Related]
10. In vitro effects of 2 antirheumatic drugs on the synthesis and expression of proinflammatory cytokines in synovial membranes from patients with rheumatoid arthritis.
Ounissi-Benkalha H; Pelletier JP; Tardif G; Mineau F; Jolicoeur FC; Ranger P; Martel-Pelletier J
J Rheumatol; 1996 Jan; 23(1):16-23. PubMed ID: 8838503
[TBL] [Abstract][Full Text] [Related]
11. Tenidap sodium does not alter the clearance or plasma protein binding of tolbutamide in healthy male volunteers.
Wilner KD; Gardner MJ
Br J Clin Pharmacol; 1995; 39 Suppl 1(Suppl 1):39S-42S. PubMed ID: 7547093
[TBL] [Abstract][Full Text] [Related]
12. Effect of tenidap sodium on the pharmacodynamics and plasma protein binding of warfarin in healthy volunteers.
Apseloff G; Wilner KD; Gerber N
Br J Clin Pharmacol; 1995; 39 Suppl 1(Suppl 1):29S-33S. PubMed ID: 7547090
[TBL] [Abstract][Full Text] [Related]
13. Rheumatoid arthritis treated with tenidap and piroxicam. Clinical associations with cytokine modulation by tenidap.
Littman BH; Drury CE; Zimmerer RO; Stack CB; Law CG
Arthritis Rheum; 1995 Jan; 38(1):29-37. PubMed ID: 7818568
[TBL] [Abstract][Full Text] [Related]
14. Tenidap: a novel cytokine-modulating antirheumatic drug for the treatment of rheumatoid arthritis.
Breedveld F
Scand J Rheumatol Suppl; 1994; 100():31-44. PubMed ID: 7532319
[TBL] [Abstract][Full Text] [Related]
15. Tenidap in patients with rheumatoid arthritis. A 4-week, placebo-controlled study.
Prupas HM; Loose LD; Spindler JS; Dietz AJ; Gum OB; Weisman MH; Gordon G; Wolf RE; Turner RA; Collins RL; Germain BF; Katz P; Ballou SP; Wolfe F; Daniels JC; April PA; Willkens RF; Pariser K; Hepburn B; Zizic TM; Ting N; Mehrban M
Scand J Rheumatol; 1996; 25(6):345-51. PubMed ID: 8996468
[TBL] [Abstract][Full Text] [Related]
16. Effect of the anti-inflammatory agent tenidap on the pharmacokinetics and pharmacodynamics of prednisolone.
Garg V; Blum R; Wilner KD; Jusko WJ
J Clin Pharmacol; 1992 Mar; 32(3):222-30. PubMed ID: 1564126
[TBL] [Abstract][Full Text] [Related]
17. Tenidap sodium decreases renal clearance and increases steady-state concentrations of lithium in healthy volunteers.
Apseloff G; Wilner KD; von Deutsch DA; Gerber N
Br J Clin Pharmacol; 1995; 39 Suppl 1(Suppl 1):25S-28S. PubMed ID: 7547089
[TBL] [Abstract][Full Text] [Related]
18. Reduction of acute-phase proteins with tenidap sodium, a cytokine-modulating anti-rheumatic drug.
Loose LD; Sipe JD; Kirby DS; Kraska AR; Weiner ES; Shanahan WR; Leeming MR; Farrow P; Stack CB; Ting N
Br J Rheumatol; 1993 Jun; 32 Suppl 3():19-25. PubMed ID: 7685226
[TBL] [Abstract][Full Text] [Related]
19. Salivary and serum procalcitonin and C-reactive protein as biomarkers of periodontitis in United States veterans with osteoarthritis or rheumatoid arthritis.
Redman RS; Kerr GS; Payne JB; Mikuls TR; Huang J; Sayles HR; Becker KL; Nylén ES
Biotech Histochem; 2016; 91(2):77-85. PubMed ID: 26800284
[TBL] [Abstract][Full Text] [Related]
20. A comparative study of tenidap, a cytokine-modulating anti-rheumatic drug, and diclofenac in rheumatoid arthritis: a 24-week analysis of a 1-year clinical trial.
Wylie G; Appelboom T; Bolten W; Breedveld FC; Feely J; Leeming MR; Le Loët X; Manthorpe R; Marcolongo R; Smolen J
Br J Rheumatol; 1995 Jun; 34(6):554-63. PubMed ID: 7543348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
